ArticleCancer immunology research2020

SHP-2 and PD-L1 Inhibition Combined with Radiotherapy Enhances Systemic Antitumor Effects in an Anti-PD-1-Resistant Model of Non-Small Cell Lung Cancer.

Dawei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.